Year 2024 / Volume 116 / Number 6
Editorial
Organization of Neurogastroenterology and Motility units with a multidisciplinary, patient-centered perspective

302-304

DOI: 10.17235/reed.2024.10368/2024

Maite Alonso-Sierra, Carolina Malagelada, Jordi Serra,

Abstract
Neurogastroenterology and Motility is a Gastroenterology subspecialty dealing with the management of gastrointestinal (GI) motor diseases and disorders of gut-brain interaction (DGBI). Both types of conditions may impair the nutritional status of patients — In the case of motility disorders, because deficient gastrointestinal motility may impair appropriate food digestion and absorption; in DGBI because development of gastrointestinal symptoms may impair appropriate patient nutrition. In both cases, different studies have shown that patients start restrictive diets on their own, without supervision of a dietician, which leads to nutritional deficits in many cases. Likewise, psychological factors like stressful situations or anxiety may trigger gastrointestinal symptoms in these patients, mainly in those with DGBI. Recent studies comparing a patient-centered approach that includes medical treatment, dietary modifications, and behavioural interventions with gastroenterologist-only standard care have shown a greater proportion of improved symptoms, psychological status, and quality of life, as well as reduced costs in patients allocated to the multidisciplinary treatment arm. In conclusion, there is growing evidence in favour of dietary and behavioural interventions by specialized professionals, coupled with appropriate medical evaluation and treatment by a gastroenterologist. Hence the importance of developing reference units in which comprehensive, individualized management may be offered. Multidisciplinary models improve clinical outcomes and patient satisfaction, which should result in a reduction of direct and indirect costs.  
Share Button
New comment
Comments
No comments for this article
References
1.Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology 2016
2. Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021;160(1):99-114.
3. Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. JAMA 2021;325(9): 865–877.
4. Goodoory VC, Ng CE, Black CJ, et al. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Aliment Pharmacol Ther 2022; 56: 110–120.
5. Staudacher HM, Black CJ, Teasdale SB, et al. Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol 2023 ; 20(9):582-596.
6. Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes 2017;15(1):35.
7. Goodoory VC, Ng CE, Black CJ, et al. Impact of Rome IV irritable bowel syndrome on work and activities of daily living. Aliment Pharmacol Ther 2022 ; 56(5):844-856.
8. Linedale EC, Shahzad MA, Kellie AR,et al. Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders. JGH Open 2017;1(3):84-91.
9. Chey WD, Keefer L, Whelan K, et alR. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology 2021;160(1):47-62.
10. Goodoory VC, Mikocka-Walus A, Yiannakou Y,et al. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol 2021 ;116(7):1485-1494.
11. Murray HB, Doerfler B, Harer KN, et al. Psychological Considerations in the Dietary Management of Patients With DGBI. Am J Gastroenterol 2022 ;117(6):985-994.
12. Basnayake C, Kamm M, Stanley A, et al. Optimal delivery of care for functional gastrointestinal disorders: randomized controlled trial of standard gastroenterologist-only care versus multidisciplinary care (MANTRA study). J Gastroenterol Hepatol 2019.
13. Basnayake C, Kamm MA, Stanley A, et al. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial. Clin Gastroenterol Hepatol 2022 ;20(9):2102-2111.
14. Ford AC, Moayyedi P, Chey WD, et al. ACG Task Force on Management of Irritable Bowel Syndrome. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol 2018 ;113(Suppl 2):1-18.
15. Eswaran SL, Chey WD, Han-Markey T, et al. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016;11:1824–1832.
16. Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 2022;71(6):1117-1126.
17. Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66(8):1517-1527.
18. Aguilar A, Malagelada C, Serra J. Nutritional challenges in patients with gastroparesis. Curr Opin Clin Nutr Metab Care 2022;25(5):360-363.
19. Ringel Y, Drossman DA. From gut to brain and back--a new perspective into functional gastrointestinal disorders.J Psychosom Res 1999 ; 47(3):205-10.
20. Staudacher HM, Mikocka-Walus A, Ford AC. Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials. Lancet Gastroenterol Hepatol 2021;6(5):401-410.
21. Kruimel J, Leue C, Winkens B, et al. Integrated medical-psychiatric outpatient care in functional gastrointestinal disorders improves outcome: a pilot study. Eur J Gastroenterol Hepatol 2015;27(6):721-7.
22. Bray NA, Koloski NA, Jones MP, et al. Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study. Dig Dis Sci 2022;67(12):5593-5601.
23. Black CJ, Thakur ER, Houghton LA, et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis.Gut 2020;69(8):1441-1451.
Related articles

Letter

Pancreatic lipoma: diagnostic boom of a rare mesenchymal tumor

DOI: 10.17235/reed.2022.8536/2021

Editorial

Diet in the etiology of inflammatory bowel disease

DOI: 10.17235/reed.2018.6119/2018

Special Article

Consensus document on exclusion diets in irritable bowel syndrome (IBS)

DOI: 10.17235/reed.2018.5941/2018

Letter to the Editor

Acute gastric dilatation after dietary violation

DOI: 10.17235/reed.2017.5111/2017

Original

Coping with celiac disease: how heavy is the burden for caregivers?

DOI: 10.17235/reed.2017.4518/2016

Citation tools
Alonso-Sierra M, Malagelada C, Serra J. Organization of Neurogastroenterology and Motility units with a multidisciplinary, patient-centered perspective. 10368/2024


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 745 visits.
This article has been downloaded 93 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 26/02/2024

Accepted: 29/02/2024

Online First: 12/03/2024

Published: 04/06/2024

Article Online First time: 15 days

Article editing time: 99 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology